For 10 years, Dr. Thompson has led the ENIGMA Consortium for Worldwide Medicine, Imaging & Genomics (http://enigma.ini.usc.edu), a worldwide medical network of 1,000 institutions across 45 countries studying the major diseases of the brain, with MRI, diffusion MRI, resting state fMRI, EEG, MEG, and genomics. ENIGMA has published the largest neuroimaging studies of 10 major brain disorders – including PTSD, schizophrenia, bipolar disorder, major depression, ADHD, autism, epilepsy, and OCD. Dr. Thompson also leaYds AI4AD (the Artificial Intelligence for Alzheimer’s Disease Initiative) – a new NIH initiative to apply deep learning to discover and understand drug targets based on whole genome sequence data and large-scale biobanks. At the University of Southern California, in Los Angeles, Paul Thompson is Associate Director for the Stevens Neuroimaging & Informatics Institute. Dr. Thompson obtained his M.A. in Mathematics and Greek & Latin Languages from Oxford University, England, and his Ph.D. in Neuroscience from UCLA. Dr. Thompson’s 1,600 published research papers combine the talents of researchers in mathematics, neuroimaging, and clinical neurology (see http://enigma.ini.usc.edu); in 2021, he was the 204th most cited scientist worldwide: http://www.webometrics.info/en/hlargerthan100.